C4 Therapeutics, Inc. - COM STK (CCCC)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM STK
Number of holders
111
Total Shares
39.2M
Shares change
-227K
Total reported value, excl. options
$231M
Value change
-$9.77M
Put/Call ratio
0.12
Number of buys
55
Number of sells
-46
Price
$5.90
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.